Ho C - Search Results

1

Prediction of Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer with High PD-L1 Expression Using Baseline CT Disease Quantification and Smoking Pack Years.

Silver A, Ho C, Ye Q, Zhang J, Janzen I, Li J, Martin M, Wu L, Wang Y, Lam S, MacAulay C, Melosky B, Yuan R. Silver A, et al. Among authors: ho c. Curr Oncol. 2023 Jun 8;30(6):5546-5559. doi: 10.3390/curroncol30060419. Curr Oncol. 2023. PMID: 37366902 Free PMC article. Clinical Trial.

2

Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America.

Ho C, Murray N, Laskin J, Melosky B, Anderson H, Bebb G. Ho C, et al. Lung Cancer. 2005 Aug;49(2):225-31. doi: 10.1016/j.lungcan.2005.02.011. Lung Cancer. 2005. PMID: 15925429

3

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

Ho C, Davies AM, Lara PN Jr, Gandara DR. Ho C, et al. Clin Lung Cancer. 2006 May;7 Suppl 4:S118-25. doi: 10.3816/clc.2006.s.003. Clin Lung Cancer. 2006. PMID: 16764752 Review.

4

Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.

Pugh TJ, Bebb G, Barclay L, Sutcliffe M, Fee J, Salski C, O'Connor R, Ho C, Murray N, Melosky B, English J, Vielkind J, Horsman D, Laskin JJ, Marra MA. Pugh TJ, et al. Among authors: ho c. BMC Cancer. 2007 Jul 13;7:128. doi: 10.1186/1471-2407-7-128. BMC Cancer. 2007. PMID: 17626639 Free PMC article.

5

Early clinical trial experience with vaccine therapies in non-small-cell lung cancer.

Ho C, Ochsenbein AF, Gautschi O, Davies AM. Ho C, et al. Clin Lung Cancer. 2008 Feb;9 Suppl 1:S20-7. doi: 10.3816/clc.2008.s.004. Clin Lung Cancer. 2008. PMID: 18540531 Review.

6

EGFR-directed therapies to treat non-small-cell lung cancer.

Ho C, Laskin J. Ho C, et al. Expert Opin Investig Drugs. 2009 Aug;18(8):1133-45. doi: 10.1517/13543780903066772. Expert Opin Investig Drugs. 2009. PMID: 19572809 Review.

7

Cetuximab in locally advanced head-and-neck cancer: defining the population.

Ho C. Ho C. Curr Oncol. 2010 Aug;17(4):48-51. doi: 10.3747/co.v17i4.696. Curr Oncol. 2010. PMID: 20697514 Free PMC article.

8

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.

Ho C, Davies AM, Sangha RS, Lau D, Lara P Jr, Chew HK, Beckett L, Mack PC, Riess JW, Gandara DR. Ho C, et al. Invest New Drugs. 2013 Dec;31(6):1587-91. doi: 10.1007/s10637-013-0024-y. Epub 2013 Sep 8. Invest New Drugs. 2013. PMID: 24013936 Free PMC article. Clinical Trial.

9

A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced disease.

Mariano C, Bosdet I, Karsan A, Ionescu D, Murray N, Laskin JJ, Zhai Y, Melosky B, Sun S, Ho C. Mariano C, et al. Among authors: ho c. Lung Cancer. 2014 Jan;83(1):73-7. doi: 10.1016/j.lungcan.2013.10.007. Epub 2013 Oct 19. Lung Cancer. 2014. PMID: 24192511 Clinical Trial.

10

Third-line chemotherapy in small-cell lung cancer: an international analysis.

Simos D, Sajjady G, Sergi M, Liew MS, Califano R, Ho C, Leighl N, White S, Summers Y, Petrcich W, Wheatley-Price P. Simos D, et al. Among authors: ho c. Clin Lung Cancer. 2014 Mar;15(2):110-8. doi: 10.1016/j.cllc.2013.11.003. Epub 2013 Nov 14. Clin Lung Cancer. 2014. PMID: 24365050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,602 results

Search Page